相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging evidence of the impact of kidney disease on drug metabolism and transport
T. D. Nolin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Downregulation of hepatic acetylation of drugs in chronic renal failure
Emilie Simard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effects of chronic renal failure on liver drug transporters
Judith Naud et al.
DRUG METABOLISM AND DISPOSITION (2008)
Effects of uptake and efflux transporter inhibition on erythromycin breath test results
L. A. Frassetto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Down-regulation of intestinal drug transporters in chronic renal failure in rats
Judith Naud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure
Jose Michaud et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Hemodialysis acutely improves hepatic CYP3A4 metabolic activity
Thomas D. Nolin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of renal failure on drug transport and metabolism
H Sun et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450
J Michaud et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Characterization of uremic toxin transport by organic anion transporters in the kidney
T Deguchi et al.
KIDNEY INTERNATIONAL (2004)
Effects of uremic toxins on hepatic uptake and metabolism of erythromycin
H Sun et al.
DRUG METABOLISM AND DISPOSITION (2004)
Cytochrome P450 regulation and drug biotransformation during inflammation and infection
KW Renton
CURRENT DRUG METABOLISM (2004)
The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction
H Okabe et al.
PHARMACEUTICAL RESEARCH (2003)
Characterization of hepatic cytochrome P4503A activity in patients with end-stage renal disease
TC Dowling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Cytochrome P4502C9 activity in end-stage renal disease
AW Dreisbach et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Drug metabolism in chronic renal failure
V Pichette et al.
CURRENT DRUG METABOLISM (2003)
Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis
I Aoyama et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Hepatic drug metabolism and transport in patients with kidney disease
TD Nolin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes
HB Wang et al.
CLINICAL PHARMACOKINETICS (2003)
The effect of chronic renal failure on hepatic drug metabolism and drug disposition
AW Dreisbach et al.
SEMINARS IN DIALYSIS (2003)
Down-regulation of hepatic cytochrome P450 in chronic renal failure:: role of uremic mediators
C Guévin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy
L Ji et al.
KIDNEY INTERNATIONAL (2002)
Downregulation of intestinal cytochrome P450 in chronic renal failure
FA Leblond et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Monitoring changes in gene expression in renal ischemia-reperfusion in the rat
T Yoshida et al.
KIDNEY INTERNATIONAL (2002)
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney
T Deguchi et al.
KIDNEY INTERNATIONAL (2002)
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion
C Veau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure
ZH Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
